A routine slit lamp exam may reveal telltale findings of health concerns elsewhere in the body.
A new study says azithromycin better improves signs and symptoms—at a lower price.
Today’s optometrists face difficult Rx decisions.
Blurry vision after an auto accident. What's the diagnosis?
Here is a snapshot of what's happening in the industry.
If ASP doesn’t do the job, here’s a more aggressive option.
This condition can affect more than just the eyelids.
Can this old-school measure hold its own in a more sophisticated era?
From the Snellen chart to the surgical suite, and everywhere in between.
Reestablishing a pH balance is key to controlling ocular damage from chemical burns.
Eyelid exams can be critical to keeping your patients healthy.
A slow-release delivery system improves treatment for CNV in mouse eyes.
Seeing spots leads to a diagnosis of idiopathic juxtafoveal retinal telangiectasis.
Can this patient’s fundus exam help you find the cause of her sudden loss of vision?
Steps to perform lacrimal dilation and irrigation.
Off-label uses present us with dilemmas to navigate on a daily basis.
Recognize when a situation calls for doctors to revert to old-model drugs.
Don't mistake this complex condition for a more typical ocular surface disorder.
Copious eye washing is the necessary first step in combating chemical splashes.
The new squalamine looks to improve outcomes, potentially expanding the OD's role.
Because of the close association between optic neuritis and MS, a prompt diagnosis and referral for treatment is paramount.
Here’s a review of the most commonly prescribed topical and oral antiviral medications used to manage herpetic eye disease.
Here is a snapshot of what is happening in the industry.
How do ocular vitamins match up to their claims?
A new bill could reinstate ODs' privileges to prescribe hydrocodone.
Using drugs off label is not only permissible, it’s often standard of care. Get to know the following non-FDA-approved indications (if you don’t know them already).
Herpes, HIV, Ebola, enterovirus and rhinovirus (the common cold) are but a few notable examples.
Oral antibiotics and analgesics often are clinically necessary when treating certain ocular conditions. Here’s a rundown of our favorite systemic agents.
Be sure to watch for these rare but disastrous adverse ocular effects in patients on
EGFR inhibitors who are being treated for cancer.
A review of the latest product offerings.
A common blood pressure medication may hold the key to treating diabetes.
Our patient with a history of rheumatoid arthritis reported a steady loss of vision.
Was her medication to blame?
Thyroid eye disease is complex and confounding. This comprehensive review connects the pathophysiology to its clinical presentation.
We've heard about these presentations, but have yet to actually see them.
A review of the latest product offerings.
Eylea provides a longer duration of effect for diabetic macular edema patients than other anti-VEGF options.
It's a common condition. What, if anything, can be done to identify and treat it?
For anti-VEGF treatment of AMD, monthly frequency and ranibizumab treatment were associated with a higher risk of geographic atrophy.
Optometrists are increasingly involved in recommending—and even performing—PIs. Here, an Oklahoma OD walks us through the procedure.
A decade ago, we looked at the latest treatment options for blepharitis. It's high time we eye them up again.
This patient returned after uncomplicated cataract surgery with an unexpected "correction" to his glaucoma. How did this happen?
Three non-routine cataract cases showcase surgical advances and highlight increasing postoperative visual expectations.
In some instances, properly medicating a patient may lead to other problems.
When ocular inflammation is too severe to manage with NSAIDs or steroids alone, consider an amniotic membrane graft.
Transzonular drug delivery during cataract surgery is a safe, convenient way to quash concerns about postoperative drug compliance.
Hydroxychloroquine (Plaquenil, Sanofi-Aventis) therapy is no better than placebo in patients with primary Sjögren’s syndrome.
Even Cleopatra would favor this simple, needle-based procedure.
This uveitis patient is also a steroid responder. Which problem do you tackle first?
Is there a role for iridotomy when managing patients with pigmentary glaucoma?
In most states, ODs can safely and effectively cauterize benign skin lesions with dichloroacetic acid.
In MGD patients, intense lid massage can cause significant corneal warping.
Optometrists play a vital role in coordinating intervention among specialists and the GP.
The latest agents, Prolensa and Ilevro, are improved formulations of current standbys for postoperative pain management.
For every 10,000 drug compounds developed, only one will achieve FDA approval.
An old glaucoma medication stages a comeback in the United States.
Patient presents after pepper spray exposure at a nightclub.
Don’t turn a blind eye to a blind eye.
Severe ocular insult is one potential casualty of airbag deployment.
Now many ODs are using steroids as a first-line therapy for allergic conjunctivitis.
What does obstructive sleep apnea have to do with eye care? A lot, actually.
You can’t afford to stay in the dark regarding these ocular and systemic side effects.
Dry eye can strike patients of any age.
Here’s a look at the best available options for treating a recurrent corneal erosion.
How does amniotic membrane implantation work?
There are countless reasons why new dry eye drugs have come up short in FDA testing.
The newer-generation topical fluoroquinolones are some of the most effective
antibiotics we’ve ever seen.
Another glaucoma patient presented with double vision.
Two case reports illustrate the visually devastating risks associated with using IV street drugs.
The debate over the use of corticosteroids for bacterial keratitis continues to rage.
This patient was already being managed for one ocular problem.
Some of these drugs might be unfamiliar now, but you may see them in topical drops soon.
Treatment options for Fuchs' have improved dramatically during the last two decades.
Allergy in children can be more difficult to diagnose and treat.
Will patients with ocular side effects soon hit your office?
Lucentis, Avastin or Eylea—what’s the difference?
We must familiarize ourselves with all available treatments for this hot topic.
Ortho-K can slow or even stop myopia progression in children.
When the meds we require aren't readily available, it’s time to get creative.
Don’t overlook the potential of OSD when treating POAG.
How to recognize and address Valsalva retinopathy.
Now, more than ever, is the time for optometry to embrace medical management.
A bipolar patient, on psychotropic meds, presented with vague visual complaints.
Supplementation along with a balanced diet will help protect patients against AMD.
When you are dealing with acute optic neuropathies, you are not looking at just one disease—but rather a spectrum of many subtypes. Understanding each one is the key to proper care.